Total Funding
39
63
Total FundingSeed raised
Growth Score
-6 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
55625
Orthogonal Thinker is a biotech holding and operating company that acquires and accelerates companies.
Jason Hobson: Co-Founder and CEO- David Nikzad: Co-Founder & Chief Executive Officer
About the Company
Orthogonal Thinker is a biotech holding company, acquiring and accelerating companies engaged in DEA registered psilocybin, psychoactive compounds, clean label foods, and plant sciences. Empowering health, mental wellness and emotional intelligence through food, technology, and psychoactive compounds.
